Conference
Efficacy of leflunomide in the treatment of vasculitis.
Abstract
OBJECTIVES: Only a few small case series, case reports, and one small clinical trial suggested some benefit of leflunomide (LEF) in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis and other vasculitides. We analysed the clinical efficacy and tolerability of LEF in a large cohort of patients with various vasculitides.
METHODS: This was a retrospective analysis of patients who received LEF for treatment of their vasculitis …
Authors
Mustapha N; Barra L; Carette S; Cuthbertson D; Khalidi NA; Koening CL; Langford CA; McAlear CA; Milman N; Moreland LW
Volume
39 Suppl 129
Pagination
pp. 114-118
Publisher
Clinical and Experimental Rheumatology
Publication Date
May 19, 2021
DOI
10.55563/clinexprheumatol/ve38dj
Conference proceedings
Clinical and Experimental Rheumatology
Issue
2
ISSN
0392-856X